BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21541746)

  • 1. Comparative modeling of 25-hydroxycholesterol-7α-hydroxylase (CYP7B1): ligand binding and analysis of hereditary spastic paraplegia type 5 CYP7B1 mutations.
    Siam A; Brancale A; Simons C
    J Mol Model; 2012 Feb; 18(2):441-53. PubMed ID: 21541746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5.
    Goizet C; Boukhris A; Durr A; Beetz C; Truchetto J; Tesson C; Tsaousidou M; Forlani S; Guyant-Maréchal L; Fontaine B; Guimarães J; Isidor B; Chazouillères O; Wendum D; Grid D; Chevy F; Chinnery PF; Coutinho P; Azulay JP; Feki I; Mochel F; Wolf C; Mhiri C; Crosby A; Brice A; Stevanin G
    Brain; 2009 Jun; 132(Pt 6):1589-600. PubMed ID: 19439420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.
    Schöls L; Rattay TW; Martus P; Meisner C; Baets J; Fischer I; Jägle C; Fraidakis MJ; Martinuzzi A; Saute JA; Scarlato M; Antenora A; Stendel C; Höflinger P; Lourenco CM; Abreu L; Smets K; Paucar M; Deconinck T; Bis DM; Wiethoff S; Bauer P; Arnoldi A; Marques W; Jardim LB; Hauser S; Criscuolo C; Filla A; Züchner S; Bassi MT; Klopstock T; De Jonghe P; Björkhem I; Schüle R
    Brain; 2017 Dec; 140(12):3112-3127. PubMed ID: 29126212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining for Oxysterols in
    Meljon A; Crick PJ; Yutuc E; Yau JL; Seckl JR; Theofilopoulos S; Arenas E; Wang Y; Griffiths WJ
    Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations.
    Arnoldi A; Crimella C; Tenderini E; Martinuzzi A; D'Angelo MG; Musumeci O; Toscano A; Scarlato M; Fantin M; Bresolin N; Bassi MT
    Clin Genet; 2012 Feb; 81(2):150-7. PubMed ID: 21214876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of Taiwanese patients with Hereditary spastic paraplegia type 5.
    Chou CT; Soong BW; Lin KP; Tsai YS; Jih KY; Liao YC; Lee YC
    Ann Clin Transl Neurol; 2020 Apr; 7(4):486-496. PubMed ID: 32202070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study.
    Criscuolo C; Filla A; Coppola G; Rinaldi C; Carbone R; Pinto S; Wang Q; de Leva MF; Salvatore E; Banfi S; Brunetti A; Quarantelli M; Geschwind DH; Pappatà S; De Michele G
    J Neurol; 2009 Aug; 256(8):1252-7. PubMed ID: 19363635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome Sequencing Reveals a Novel Homozygous Frameshift Mutation in the CYP7B1 Gene in a Japanese Patient with SPG5.
    Nan H; Shimozono K; Ichinose Y; Tsuchiya M; Koh K; Hiraide M; Takiyama Y
    Intern Med; 2019 Mar; 58(5):719-722. PubMed ID: 30333426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the CYP7B1, PNPLA6 and C19orf12 genes in autosomal recessive hereditary spastic paraplegia.
    Schubert SF; Hoffjan S; Dekomien G
    Mol Cell Probes; 2016 Feb; 30(1):53-5. PubMed ID: 26714052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter lesions in spastic paraplegia with mutations in SPG5/CYP7B1.
    Biancheri R; Ciccolella M; Rossi A; Tessa A; Cassandrini D; Minetti C; Santorelli FM
    Neuromuscul Disord; 2009 Jan; 19(1):62-5. PubMed ID: 19187859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.
    Marelli C; Lamari F; Rainteau D; Lafourcade A; Banneau G; Humbert L; Monin ML; Petit E; Debs R; Castelnovo G; Ollagnon E; Lavie J; Pilliod J; Coupry I; Babin PJ; Guissart C; Benyounes I; Ullmann U; Lesca G; Thauvin-Robinet C; Labauge P; Odent S; Ewenczyk C; Wolf C; Stevanin G; Hajage D; Durr A; Goizet C; Mochel F
    Brain; 2018 Jan; 141(1):72-84. PubMed ID: 29228183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP7B1: novel mutations and magnetic resonance spectroscopy abnormalities in hereditary spastic paraplegia type 5A.
    Roos P; Svenstrup K; Danielsen ER; Thomsen C; Nielsen JE
    Acta Neurol Scand; 2014 May; 129(5):330-4. PubMed ID: 24117163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPG5 and multiple sclerosis: clinical and genetic overlap?
    Criscuolo C; Carbone R; Lieto M; Peluso S; Guacci A; Filla A; Quarantelli M; Lanzillo R; Morra VB; De Michele G
    Acta Neurol Scand; 2016 Jun; 133(6):410-4. PubMed ID: 26370385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic analysis of Taiwanese patients with hereditary spastic paraplegia type 5.
    Lan MY; Yeh TH; Chang YY; Kuo HC; Sun HS; Lai SC; Lu CS
    Eur J Neurol; 2015 Jan; 22(1):211-4. PubMed ID: 24641183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of CYP7B1 in non-consanguineous cases of hereditary spastic paraplegia.
    Schüle R; Brandt E; Karle KN; Tsaousidou M; Klebe S; Klimpe S; Auer-Grumbach M; Crosby AH; Hübner CA; Schöls L; Deufel T; Beetz C
    Neurogenetics; 2009 Apr; 10(2):97-104. PubMed ID: 18855023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and dynamic basis of human cytochrome P450 7B1: a survey of substrate selectivity and major active site access channels.
    Cui YL; Zhang JL; Zheng QC; Niu RJ; Xu Y; Zhang HX; Sun CC
    Chemistry; 2013 Jan; 19(2):549-57. PubMed ID: 23180418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplicon-based high-throughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients.
    Schlipf NA; Schüle R; Klimpe S; Karle KN; Synofzik M; Schicks J; Riess O; Schöls L; Bauer P
    Clin Genet; 2011 Aug; 80(2):148-60. PubMed ID: 21623769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
    Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
    Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
    Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP7B1 mutations in French-Canadian hereditary spastic paraplegia subjects.
    Noreau A; Dion PA; Szuto A; Levert A; Thibodeau P; Brais B; Dupré N; Rioux MF; Rouleau GA
    Can J Neurol Sci; 2012 Jan; 39(1):91-4. PubMed ID: 22384504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.